Altman Peter

High conviction

Director, President and CEO · BioCardia, Inc.

Every open-market stock purchase Altman Peter has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where how the prices paid compare to where the stock trades now.

Total bought

$16.6K

Open-market buys

Companies

Last buy

Jul 17, 2026

Where the buys stand today

BCDA
BioCardia, Inc.
7 purchases totalling $16.6K at an average of $0.94 per share. See all insider buying in BCDA →
Avg price paid
$0.94
Latest price
—
Market cap
Unknown

All reported buys

Date	Ticker	Shares	Price	Value	Filing
Jul 17, 2026	BCDA	500	$0.83	$415.0	SEC ↗
Jul 15, 2026	BCDA	1,500	$0.86	$1.3K	SEC ↗
Jul 14, 2026	BCDA	2,800	$0.88	$2.5K	SEC ↗
Jul 10, 2026	BCDA	1,000	$0.94	$940.0	SEC ↗
Jul 9, 2026	BCDA	1,000	$0.90	$900.0	SEC ↗
Jul 8, 2026	BCDA	5,500	$0.97	$5.3K	SEC ↗
Jul 8, 2026	BCDA	5,400	$0.96	$5.2K	SEC ↗

Get alerted the next time Altman Peter — or any insider — buys

We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.

Get alerts free See pricing

About this data

Figures are parsed from Altman Peter's Form 4 filings on SEC EDGAR (CIK 1647542) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.